TCL Archive Drug Development: Tivozanib Trial Discontinued Due to Insufficient Enrollment February 7, 2014
TCL Archive NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object September 19, 1986
TCL Archive Race And Cancer: “It Would Be Wrong To Design Studies Based On Assumptions That Races Are Biologically Different,” Klausner Says June 19, 1998
